C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 21.1 NOK Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Carasent ASA
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Carasent ASA
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
C
Carasent ASA
OSE:CARA
Total Receivables
kr57.1m
CAGR 3-Years
34%
CAGR 5-Years
48%
CAGR 10-Years
16%
N
Nordhealth AS
OSE:NORDH
Total Receivables
€5.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Omda AS
OSE:OMDA
Total Receivables
kr73.1m
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
N/A
No Stocks Found

Carasent ASA
Glance View

Market Cap
1.5B NOK
Industry
Health Care

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

CARA Intrinsic Value
23.26 NOK
Undervaluation 9%
Intrinsic Value
Price
C

See Also

What is Carasent ASA's Total Receivables?
Total Receivables
57.1m NOK

Based on the financial report for Jun 30, 2024, Carasent ASA's Total Receivables amounts to 57.1m NOK.

What is Carasent ASA's Total Receivables growth rate?
Total Receivables CAGR 10Y
16%

Over the last year, the Total Receivables growth was 38%. The average annual Total Receivables growth rates for Carasent ASA have been 34% over the past three years , 48% over the past five years , and 16% over the past ten years .

Back to Top